|Mr. Irwin David Simon||Pres, CEO & Chairman||13.68M||N/A||1958|
|Mr. Carl A. Merton CA, CBV, CPA||CFO & Principal Accounting Officer||1.13M||98.24k||1970|
|Mr. James R. Meiers||Chief Operations Officer||1.2M||N/A||1958|
|Ms. Denise Menikheim Faltischek||Head of International & Chief Strategy Officer||1.19M||N/A||1973|
|Mr. Lloyd Brathwaite||Chief Information Officer||N/A||N/A||N/A|
|Mr. John B. Sadler||VP of Investor Relations||N/A||N/A||N/A|
|Ms. Dara Redler||Interim Chief Legal Officer & Corp. Sec.||N/A||N/A||N/A|
|Mr. Bernard Yeung||Sr. VP of Sales & Marketing||N/A||N/A||N/A|
|Ms. Rita Seguin||Chief HR Officer||N/A||N/A||N/A|
|Mr. Victor Neufeld CA, CPA, MBA||Special Advisor||N/A||N/A||1954|
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Tilray, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.